Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bone mineral density in children with acute lymphoblastic leukemia.

Cancer - 1 Mar 2018

Inaba Hiroto, Cao Xueyuan, Han Alice Q, Panetta John C, Ness Kirsten K, Metzger Monika L, Rubnitz Jeffrey E, Ribeiro Raul C, Sandlund John T, Jeha Sima, Cheng Cheng, Pui Ching-Hon, Relling Mary V, Kaste Sue C

Abstract excerpt

BACKGROUND: Children with acute lymphoblastic leukemia (ALL) can develop reduced bone mineral density (BMD). However, data from patients who received treatment on a frontline regimen without cranial irradiation are limited, and no genome-wide analysis has been reported. METHODS: Lumbar BMD was evaluated by quantitative computed tomography at diagnosis, after 120 weeks of continuation therapy, and after 2 years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Bone Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium-Binding Proteins

Share to Collagen Type XI

Share to Dexamethasone

Share to Nerve Tissue Proteins

Share to Osteogenesis

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Source

Open in PubMed Open full text

Identifiers

PMID: 29266176
DOI: 10.1002/cncr.31184
PMCID: PMC5821586

Genes

NELL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bone mineral density in children with acute lymphoblastic leukemia.PMID 29266176Read ↗

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.Semantic proximity Read ↗

CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.Semantic proximity Read ↗

The Vitamin D Status in Children with Newly Diagnosed Acute Lymphoblastic Leukaemia and its Potential Impact on Primary Symptoms of Leukaemia and Course of Induction Treatment.Semantic proximity Read ↗

Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.Semantic proximity Read ↗

Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.Semantic proximity Read ↗

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalitiesSemantic proximity Read ↗

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

Modifiable Factors Associated With Aging Phenotypes Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.Semantic proximity Read ↗

Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.